PCAR vs UPB · P/E 25, rev $33.66B vs rev $2.9M
PACCAR Inc (PCAR) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
PCAR currently screens at market cap $61.75B and trailing P/E 25.0. UPB currently screens at market cap $407.3M.
Not investment advice. Open the PCAR and UPB stock pages for the full models.
Not investment advice.